Aperio Group’s Teva Pharmaceuticals TEVA Stock Holding History

Aperio Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$1.19M	Sell	122,805 -134,522	-52%	-$1.3M	﹤0.01%	1498
2020 Q3	$2.32M	Sell	257,327 -10,269	-4%	-$92.5K	0.01%	1051
2020 Q2	$3.3M	Buy	267,596 +415	+0.2%	+$5.12K	0.01%	890
2020 Q1	$2.4M	Buy	267,181 +15,678	+6%	+$141K	0.01%	945
2019 Q4	$2.47M	Buy	251,503 +78,405	+45%	+$768K	0.01%	1002
2019 Q3	$1.19M	Buy	173,098 +49,641	+40%	+$342K	﹤0.01%	1309
2019 Q2	$1.14M	Sell	123,457 -88,210	-42%	-$815K	﹤0.01%	1346
2019 Q1	$3.32M	Sell	211,667 -47,815	-18%	-$750K	0.01%	839
2018 Q4	$4M	Sell	259,482 -105,095	-29%	-$1.62M	0.02%	725
2018 Q3	$7.85M	Sell	364,577 -1,643	-0.4%	-$35.4K	0.03%	524
2018 Q2	$8.91M	Buy	366,220 +74,131	+25%	+$1.8M	0.04%	475
2018 Q1	$4.99M	Buy	292,089 +30,860	+12%	+$527K	0.02%	660
2017 Q4	$4.95M	Buy	261,229 +88,374	+51%	+$1.67M	0.03%	645
2017 Q3	$3.04M	Sell	172,855 -20,061	-10%	-$353K	0.02%	785
2017 Q2	$6.41M	Buy	192,916 +17,634	+10%	+$586K	0.04%	504
2017 Q1	$5.63M	Sell	175,282 -17,273	-9%	-$554K	0.04%	507
2016 Q4	$6.98M	Sell	192,555 -316,142	-62%	-$11.5M	0.05%	404
2016 Q3	$23.4M	Buy	508,697 +54,213	+12%	+$2.49M	0.17%	142
2016 Q2	$22.8M	Buy	454,484 +17,510	+4%	+$880K	0.18%	134
2016 Q1	$23.4M	Sell	436,974 -3,071	-0.7%	-$164K	0.2%	118
2015 Q4	$28.9M	Buy	440,045 +56,542	+15%	+$3.71M	0.26%	83
2015 Q3	$21.7M	Buy	383,503 +37,414	+11%	+$2.11M	0.22%	109
2015 Q2	$20.5M	Buy	346,089 +51,966	+18%	+$3.07M	0.21%	112
2015 Q1	$18.3M	Buy	294,123 +50,279	+21%	+$3.13M	0.21%	113
2014 Q4	$14M	Buy	243,844 +39,546	+19%	+$2.27M	0.17%	138
2014 Q3	$11M	Buy	204,298 +14,350	+8%	+$771K	0.15%	169
2014 Q2	$9.96M	Buy	189,948 +11,933	+7%	+$626K	0.14%	183
2014 Q1	$9.41M	Buy	+178,015	New	+$9.41M	0.13%	185
2013 Q4	–	Sell	-137,804	Closed	-$5.21M	–	270
2013 Q3	$5.21M	Buy	137,804 +16,504	+14%	+$623K	0.1%	259
2013 Q2	$4.76M	Buy	+121,300	New	+$4.76M	0.11%	213